Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 5/20 | 0.32 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.32 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.32 |
| ▸ | AMD1 | P17707 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TPH1 | P17752 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29352185 | 0.98 | HTR7 (0.33) | HTR7ADRA1DADRA1AADRA1BAMD1 | |
| SCHEMBL117903 | 0.98 | HTR7 (0.33) | HTR7ADRA1DADRA1AADRA1BAMD1 | |
| SCHEMBL22188696 | 0.98 | HTR7 (0.33) | HTR7ADRA1DADRA1AADRA1BAMD1 | |
| SCHEMBL14567627 | 0.88 | SCN9A (0.30) | SCN9ATPH1 | |
| SCHEMBL9240771 | 0.87 | ADRB2 (0.40) | HTR7ADRA1DADRA1AADRA1BTSHR | |
| SCHEMBL9066890 | 0.86 | HTR7 (0.32) | HTR7ADRA1DADRA1AADRA1BTSHR | |
| SCHEMBL27605123 | 0.86 | LMNA (0.36) | HTR7ADRA1DADRA1AADRA1BKDM4E | |
| SCHEMBL6677056 | 0.85 | KDM4E (0.30) | KDM4E | |
| SCHEMBL9915543 | 0.81 | LMNA (0.40) | HTR7ADRA1DADRA1AADRA1BTSHR | |
| SCHEMBL3433358 | 0.81 | HTR7 (0.39) | HTR7ADRA1DADRA1AADRA1BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9060516-B2 | Method for controlling aquatic weeds | BASF SE (DE) | 2015-06-23 | — | — | US | claimed |
| US-20100093540-A1 | Control of submerged aquatic vegitation | BASF SE (DE) | 2010-04-15 | — | — | US | claimed |
| WO-2009127635-A1 | CONTROL OF SUBMERGED AQUATIC VEGETATION | BASF SE (DE) | 2009-10-22 | — | — | WO | claimed |
| US-20090011934-A1 | Method for Controlling Aquatic Weeds | BASF SE (DE) | 2009-01-08 | — | — | US | claimed |
| EP-1976383-A2 | A METHOD FOR CONTROLLING AQUATIC WEEDS | BASF SE (DE) | 2008-10-08 | — | — | EP | claimed |
| WO-2007071730-A2 | A METHOD FOR CONTROLLING AQUATIC WEEDS | BASF SE (DE) | 2007-06-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100093540-A1 | Control of submerged aquatic vegitation | CBR3, VAT1, EGLN3 | HTR7 4581/4885ADRA1D 1858/4885ADRA1A 2246/4885 |
| US-20090011934-A1 | Method for Controlling Aquatic Weeds | NOTUM, AQP3, CBR3 | HTR7 4327/4885ADRA1D 1261/4885ADRA1A 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.